Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?

BACKGROUND: The rising number of infections due to Severe Acute Respiratory Syndrome Coronavirus-2 (popularly known as COVID-19) has brought to the fore new antiviral drugs as possible treatments, including favipiravir. However, there is currently no data regarding the safety of this drug in patient...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Pediatr Nephrol
Autori principali: Ozsurekci, Yasemin, Oygar, Pembe Derin, Gürlevik, Sibel Laçinel, Kesici, Selman, Ozen, Seza, Kurt Sukur, Eda Didem, Gülhan, Bora, Topaloglu, Rezan, Bayrakci, Benan, Cengiz, Ali Bülent
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Berlin Heidelberg 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8140325/
https://ncbi.nlm.nih.gov/pubmed/34021797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-021-05111-x
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi